[Update on the mechanism of action of synthetic antiestrogens]
- PMID: 2683972
[Update on the mechanism of action of synthetic antiestrogens]
Abstract
Synthetic antiestrogens are drugs commonly used in the endocrine therapy of breast cancer. Their pharmacology is complex, most of them presenting a partial estrogenic effect. Their action via the estrogen receptor (ER) has been better understood through the use of cellular models. The antihormone-ER complex binds to estrogen responsive elements on DNA, but is unable to mimic exactly the transcriptional activation induced by the estradiol-ER complex. The antiproliferative effect of these antihormones, mainly cystostatic but also cytotoxic, is the result of the competitive inhibition of estrogens, and might also involve interaction with other cellular mediators (stimulation of inhibitory factors, and growth factors inhibition). The term antiestrogen seems therefore to be too restrictive and it may be more accurate to name them estrogen-receptor mediated drugs inhibiting cell proliferation.
Similar articles
-
Cellular and molecular mechanism of action of antiestrogens.J Steroid Biochem. 1983 Jul;19(1A):69-74. J Steroid Biochem. 1983. PMID: 6887874
-
Antiestrogen pharmacology and mechanism of action.J Steroid Biochem. 1983 Jul;19(1A):59-68. J Steroid Biochem. 1983. PMID: 6887873
-
[Recent data on the mechanism of action of synthetic antiestrogens].Biochimie. 1982 Feb;64(2):89-98. doi: 10.1016/s0300-9084(82)80411-2. Biochimie. 1982. PMID: 7039690 Review. French.
-
Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.Breast Cancer Res Treat. 1985;5(3):231-43. doi: 10.1007/BF01806018. Breast Cancer Res Treat. 1985. PMID: 4027393
-
Nonsteroidal antiestrogens are estrogen-receptor-targeted growth inhibitors that can act in the absence of estrogens.Horm Res. 1987;28(2-4):196-201. doi: 10.1159/000180944. Horm Res. 1987. PMID: 3331372 Review.